Clinical Research Funding SchemeNovember 2025CRISTAL-APC: a multi-centre, open label Phase 1/randomised Phase 2 study of VP-002, a C-C motif chemokine receptor 1 inhibitor, given orally in combination with...
The Verdict
ClassificationLikely AI
ConfidenceMedium confidence
Analyzedtext
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/22432bb3-e6ae-434e-bb8f-6d6c290c136c)